Vaishali N Geib, MD | |
172 Linden Dr, Suite 100, Winchester, VA 22601-2891 | |
(540) 722-8172 | |
(540) 723-0386 |
Full Name | Vaishali N Geib |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 30 Years |
Location | 172 Linden Dr, Winchester, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114965399 | NPI | - | NPPES |
P00140652 | Other | VA | MEDICARE RAILROAD |
OB179 | Other | FL | MEDICARE HF |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | ME148945 (Florida) | Secondary |
207R00000X | Internal Medicine | 0101052939 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Winchester Medical Center | Winchester, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
Danaher Corporation announced today that GAAP net earnings for the quarter ended October 1, 2010 were $646.4 million, or $0.95 per diluted share, which includes a $0.34 gain related to the formation of the Apex Tool Group joint venture, and represents a 79% increase as compared to GAAP net earnings per diluted share of $0.53 for the third quarter 2009.
The WHO Regional Committee for the Western Pacific meeting continued with leaders discussing regional immunization goals, public health emergencies, TB control, and the health effects of urbanization, multiple news outlets report.
Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine.
› Verified 3 days ago
Entity Name | Privia Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
Danaher Corporation announced today that GAAP net earnings for the quarter ended October 1, 2010 were $646.4 million, or $0.95 per diluted share, which includes a $0.34 gain related to the formation of the Apex Tool Group joint venture, and represents a 79% increase as compared to GAAP net earnings per diluted share of $0.53 for the third quarter 2009.
The WHO Regional Committee for the Western Pacific meeting continued with leaders discussing regional immunization goals, public health emergencies, TB control, and the health effects of urbanization, multiple news outlets report.
Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Vaishali N Geib, MD 172 Linden Dr, Suite 100, Winchester, VA 22601-2891 Ph: (540) 722-8172 | Vaishali N Geib, MD 172 Linden Dr, Suite 100, Winchester, VA 22601-2891 Ph: (540) 722-8172 |
News Archive
Danaher Corporation announced today that GAAP net earnings for the quarter ended October 1, 2010 were $646.4 million, or $0.95 per diluted share, which includes a $0.34 gain related to the formation of the Apex Tool Group joint venture, and represents a 79% increase as compared to GAAP net earnings per diluted share of $0.53 for the third quarter 2009.
The WHO Regional Committee for the Western Pacific meeting continued with leaders discussing regional immunization goals, public health emergencies, TB control, and the health effects of urbanization, multiple news outlets report.
Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine.
› Verified 3 days ago
Dr. Raveen Chawla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Neal S Gaither, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Lee Resta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Campus Blvd Ste 100, Winchester, VA 22601 Phone: 540-662-1108 | |
Kristine Gade Reed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 Campus Blvd., Suite 100, Winchester, VA 22601 Phone: 540-662-1108 Fax: 540-450-2244 | |
Dr. David Jack Lecronier, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 190 Campus Blvd Ste 201, Winchester, VA 22601 Phone: 540-536-5980 Fax: 540-536-5979 | |
T. Glen Bouder, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8874 Fax: 540-536-7847 | |
Dr. Manish J Lakhani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 |